Identification of BACE1 inhibitors from Panax ginseng saponins - An Insilco approach

BACE1, a β secretase candidate enzyme, initiates the Alzheimer's disease (AD) pathogenesis via amyloid β (Aβ) peptide production serving as a potential therapeutic target. Previous experimental evidence suggested that ginsenosides, a key component of Panax ginseng, are effective against AD. In this study, we implemented a molecular modeling method to reveal the inhibitory action of ginsenosides on BACE1 activity. We selected 12 ginsenosides and performed molecular docking studies to evaluate its interaction with the BACE1 active site, which is essential for inhibition. Further ADMET filtration was applied to find drug-like molecules with a specific ability to cross blood brain barrier (BBB), and to determine toxicity. The BACE1-ginsenosides complex was further subjected to a molecular dynamics simulation to study the stability of the complex and its hydrogen bond interactions. In summary, our findings show ginsenosides CK, F1, Rh1 and Rh2 are potential BACE1 inhibitors from Panax ginseng.

[1]  I. Kola,et al.  BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. , 2001, Human molecular genetics.

[2]  O. Lazarov,et al.  Neurogenesis and Alzheimer's disease: At the crossroads , 2010, Experimental Neurology.

[3]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[4]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.

[5]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[6]  Valérie Wilquet,et al.  Amyloid-beta precursor protein processing in neurodegeneration , 2004, Current Opinion in Neurobiology.

[7]  Kwang-tae Choi,et al.  Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer , 2008, Acta Pharmacologica Sinica.

[8]  R. Vassar,et al.  β-Secretase (BACE) as a drug target for alzheimer’s disease , 2002 .

[9]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[10]  E. Masliah,et al.  Molecular mechanisms of neurodegeneration in Alzheimer's disease. , 2010, Human molecular genetics.

[11]  P E Bourne,et al.  The Protein Data Bank. , 2002, Nucleic acids research.

[12]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[13]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[14]  Katrin Stierand,et al.  Drawing the PDB: Protein-Ligand Complexes in Two Dimensions. , 2010, ACS medicinal chemistry letters.

[15]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[16]  T K Yun,et al.  Brief introduction of Panax ginseng C.A. Meyer. , 2001, Journal of Korean medical science.

[17]  A Ljungh,et al.  Interactions of bacterial adhesins with extracellular matrix and plasma proteins: pathogenic implications and therapeutic possibilities. , 1996, FEMS immunology and medical microbiology.

[18]  B. Strooper,et al.  The secretases: enzymes with therapeutic potential in Alzheimer disease , 2010, Nature Reviews Neurology.

[19]  Rudi D'Hooge,et al.  Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient Mice* , 2005, Journal of Biological Chemistry.

[20]  So-Young Park,et al.  Potential therapeutic agents against Alzheimer’s disease from natural sources , 2010, Archives of pharmacal research.

[21]  Tam Doan,et al.  Antagonistic Effects of β-Site Amyloid Precursor Protein-cleaving Enzymes 1 and 2 on β-Amyloid Peptide Production in Cells* , 2003, Journal of Biological Chemistry.

[22]  Markus Christen,et al.  The GROMOS software for biomolecular simulation: GROMOS05 , 2005, J. Comput. Chem..

[23]  C. Schnitzler,et al.  BACE2, a β-secretase homolog, cleaves at the β site and within the amyloid-β region of the amyloid-β precursor protein , 2000 .

[24]  Yun Tang,et al.  Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors , 2007, Acta Pharmacologica Sinica.

[25]  F. Koehn,et al.  The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.

[26]  Deok-Chun Yang,et al.  Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng , 2012, Journal of enzyme inhibition and medicinal chemistry.

[27]  Alexander D. MacKerell,et al.  CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields , 2009, J. Comput. Chem..

[28]  W. Thies,et al.  2008 Alzheimer’s disease facts and figures , 2008, Alzheimer's & Dementia.

[29]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[30]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[31]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997 .

[32]  Dik-Lung Ma,et al.  Molecular docking for virtual screening of natural product databases , 2011 .

[33]  Na Li,et al.  Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. , 2007, Journal of ethnopharmacology.

[34]  Guanhua Du,et al.  Ginsenoside Rg1 inhibits β-secretase activity in vitro and protects against Aβ-induced cytotoxicity in PC12 cells , 2009, Journal of Asian natural products research.

[35]  Wei Zhang,et al.  Recent advances in computational prediction of drug absorption and permeability in drug discovery. , 2006, Current medicinal chemistry.

[36]  Hai-Tao Wang,et al.  Ginsenoside Rb1 protects PC12 cells against β-amyloid-induced cell injury. , 2010, Molecular medicine reports.

[37]  S. Nah,et al.  Neuroprotective Effects of Ginsenoside Rg 3 against 24-OH-cholesterol- induced Cytotoxicity in Cortical Neurons , 2010 .

[38]  Deok-Chun Yang,et al.  Computer-aided identification of EGFR tyrosine kinase inhibitors using ginsenosides from Panax ginseng , 2013, Comput. Biol. Medicine.

[39]  David G. Tew,et al.  Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase , 1999, Molecular and Cellular Neuroscience.

[40]  Philippe Vayer,et al.  Toward in silico structure-based ADMET prediction in drug discovery. , 2012, Drug discovery today.

[41]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[42]  C. G. Mohan,et al.  Computer-assisted methods in chemical toxicity prediction. , 2007, Mini reviews in medicinal chemistry.

[43]  Xiangwei Kong,et al.  Protective effects of ginsenoside Rd on PC12 cells against hydrogen peroxide. , 2008, Biological & pharmaceutical bulletin.

[44]  Deok-Chun Yang,et al.  Characteristics of Absorption and Accumulation of Inorganic Germanium in Panax ginseng C. A. Meyer , 2011 .

[45]  Katrin Stierand,et al.  PoseView -- molecular interaction patterns at a glance , 2010, J. Cheminformatics.

[46]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[47]  M. Weiner,et al.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.

[48]  J. Tang,et al.  Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Khaled Radad,et al.  Ginsenosides and Their CNS Targets , 2011, CNS neuroscience & therapeutics.

[50]  R. Barbour,et al.  Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.

[51]  A. Stamford,et al.  Potent pyrrolidine- and piperidine-based BACE-1 inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[52]  K. Leung,et al.  Pharmacology of ginsenosides: a literature review , 2010, Chinese medicine.